News Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:41 2024-04-19 am EDT			5-day change	1st Jan Change
2,006 ^DKK	+0.58%		-2.95%	-6.91%

Apr. 16	Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	MT
Apr. 16	Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	CI

Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug	Apr. 16	MT
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024	Apr. 16	GL
Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024	Apr. 16	CI
Transactions in Connection with Share Buy-back Program Genmab	Apr. 15	GL
Health Care Slips on Risk Bias -- Health Care Roundup	Apr. 11	DJ
Transactions in Connection with Share Buy-back Program	Apr. 08	GL
Health Care Flat on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	Apr. 03	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	Apr. 03	DJ
ADC oncology acquisition to address solid tumours	Apr. 03	AQ
Global markets live: Swiss Re, Intel, Walt Disney, Paramount, Microsoft...	Apr. 03
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	Apr. 03	DJ
Correction to Genmab Article	Apr. 03	DJ
Genmab: acquisition of ProfoundBio greeted without emotion	Apr. 03	CF
News Highlights : Top Company News of the Day - Wednesday at 7 AM ET	Apr. 03	DJ
Genmab A/S Re-Affirms Revenue Guidance for the Year 2024	Apr. 03	CI
Transcript : Genmab A/S, ProfoundBio - M&A Call	Apr. 03
European Midday Briefing : Stocks Continue to Struggle Despite Cooling Inflation	Apr. 03	DJ
News Highlights : Top Company News of the Day - Wednesday at 5 AM ET	Apr. 03	DJ
Genmab Strengthens Oncology Portfolio With $1.8 Billion Acquisition of ProfoundBio	Apr. 03	DJ
Genmab Looks to Expand Clinical Pipeline with $1.8 Billion Purchase of Cancer-focused ProfoundBio	Apr. 03	MT

No results for this search

GENMAB : Genmab is available at a bargain price

March 04, 2024 at 06:10 am EST